Tuesday, May 12, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Features | New Study Explains How Sars Cov 2 May Seize Human Cells

New study explains how SARS-CoV-2 may seize human cells

Scientists know that SARS-CoV-2 binds the ACE2 receptor on the surface of human cells, after which it enters the cell through a process known as endocytosis.

By ANI
Published Date - 22 January 2021, 11:13 AM
New study explains how SARS-CoV-2 may seize human cells
Representational Image
whatsapp facebook twitter telegram

Washington: Another detailed study by the American Association for the Advancement of Science asserts that the SARS-CoV-2 virus not only targets to enter the human cells but begin to replicate and spread as well.

The findings also highlight that the possibilities could potentially serve as targets for new therapies for patients with COVID-19, although validation in cells and animal models is needed.


Scientists know that SARS-CoV-2 binds the ACE2 receptor on the surface of human cells, after which it enters the cell through a process known as endocytosis.

Research has suggested that the virus may hijack or interfere with other processes such as cellular housekeeping (autophagy) by targeting other receptors called integrins. However, not much is known about exactly how the virus takes advantage of integrins on the biochemical level. Analyzing the Eukaryotic Linear Motif database, Balint Meszaros and colleagues discovered that ACE2 and various integrins contained several short linear motifs (SLiMs ) – small amino acid sequences – that they predicted to play a role in endocytosis and autophagy.

The scientists then compiled a list of currently used experimental treatments and approved drugs that can target the interactions between SARS-CoV-2 and its target SLiMs. Separately, Johanna Kliche and colleagues performed molecular tests to see whether these SLiMs interacted with proteins that contribute to autophagy and endocytosis.

The team found that two SLiMs in ACE2 bound to the endocytosis-related proteins SNX27 and SHANK, and one SLiM in the integrin Beta-3 bound to two proteins involved in autophagy. In addition to providing a resource for repurposing drugs for SARS-CoV-2, Meszaros et al. say their prediction methods could help identify similar under-the-radar SLiMs that assist with the replication of other viruses that cause disease.

  • Follow Us :
  • Tags
  • Corona Virus Deaths
  • Coronavirus
  • Coronavirus in India
  • coronavirus infection

Related News

  • Telangana BIE mandates anti-drug affidavit for 2026-27 admissions

    Telangana BIE mandates anti-drug affidavit for 2026-27 admissions

  • GHMC reports 1.27 lakh online self-enumeration entries

    GHMC reports 1.27 lakh online self-enumeration entries

  • Eight held in Hyderabad for killing man over ganja dispute

    Eight held in Hyderabad for killing man over ganja dispute

  • BRSV accuses Congress and BJP of political nexus in Telangana

    BRSV accuses Congress and BJP of political nexus in Telangana

Latest News

  • Manchu Manoj, activists demand swift action in POCSO case against Bandi Sanjay’s son

    7 mins ago
  • Three arrested for murder of Dalit youth in Peddapalli

    29 mins ago
  • DCP Ritiraj supervises POCSO case probe against Union Minister’s son

    1 hour ago
  • Opinion: Child absenteeism and learning gaps in Telangana’s rural schools

    1 hour ago
  • Bageerath POCSO case: FIR reveals shocking details

    1 hour ago
  • Editorial: Tough challenges ahead for BJP in Bengal

    2 hours ago
  • Indian girls secure eight final berths and four bronze medals

    2 hours ago
  • Delhi Capitals beat PBKS by three wickets, keep playoff hopes alive

    2 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam